Minimize Uncertainty – Make Informed Decisions – Succeed

Cell_Gene_Therapy

Cell and Gene Therapy Today—March 19, 2026

March 19, 2026Sarepta Therapeutics,EN001,Apertura Gene Therapy,Duchenne Muscular Dystrophy,DTX301,Elevidys,Ornithine Transcarbamylase Deficiency,BioPharma and Tech News,Albert Einstein College of Medicine,CAR T,HCW9206,hemophilia b,Human Immunodeficiency Virus,Leukemia,Sana Biotechnology,type 1 diabetes,UP421,Ultragenyx,Grit Biotechnologies,Solid Biosciences,uBriGene Biosciences,Hemgenix,GT307,Cell and Gene Therapy News,SGT-003,Charcot Marie Tooth disease type 1A,CSL,Tumor-infiltrating lymphocyte therapy,ViralgenENCell,Central Nervous System Gene Therapy

This week’s Gene and Cell Therapy update highlights clinical progress,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Crossbow Therapeutics $77 million Series B for TCR-mimetics

March 19, 2026Oncology,venture capital,clinical trials,market access,AML,biopharma,Lucid Diligence Brief,T-cell engager,TCR-mimeticHLA-restricted

Lucid Diligence Brief: Crossbow Therapeutics $77 million Series B for…

by Timos Papagatsias

Women's_Health

Women’s Health Today—March 18, 2026

March 18, 2026Genmab,American Urological Association,Estrogen Receptor-Positive Breast Cancer,Local Estrogen Therapy,astrazeneca,LYMPHIR,Genitourinary Syndrome Of Menopause,roche,Citius Oncology,Recurrent Urinary Tract Infection,BioPharma and Tech News,Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer,Ovarian Cancer,Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer,endometrial cancer,Tivdak,Maternal Health,Tisotumab Vedotin,reproductive health,Recurrent Cervical Cancer,ENHERTU,Metastatic Cervical Cancer,Akeso,Denileukin Diftitox-Cxdl,cadonilimab,Gynecologic Cancers,Daiichi Sankyo,UNFPA,trastuzumab deruxtecan,FIGO,giredestrant,HHSWomen's Health News,Office On Women’s Health

This biweekly Women’s Health update highlights regulatory momentum, late-stage…

by LucidQuest

Neuroscience

Neuroscience Today—March 18, 2026

March 18, 2026SciSparc,NeuroThera Labs,Alzheimer's Disease,Clearmind Medicine,roche,MEAI,Duchenne Muscular Dystrophy,Palmitoylethanolamide,BioPharma and Tech News,Oragenics,Glioblastoma,ONP-002,Plus Therapeutics,Concussion,Neuroscience News,Mild Traumatic Brain Injury,amyotrophic lateral sclerosis,NurExone Biologic,Major depressive disorder,Elecsys ApoE4,Leptomeningeal metastases,Amlogenyx,(Z)-Endoxifen,AM805,Atossa Therapeutics,NeuroSense,REYOBIQPrimeC,CNSide

This week’s Neuroscience update highlights regulatory progress, clinical data…

by LucidQuest

Immunology

Immunology Today—March 18, 2026

March 18, 2026Cosentyx,gastroesophageal junction cancer,Our Insights,EULAR,astrazeneca,Durvalumab,novartis,Secukinumab,Atopic Dermatitis,Almirall,BioPharma and Tech News,Lebrikizumab,psoriatic arthritis,SkinVision,melanoma,Spyre Therapeutics,gastric cancer,Ilumya,Imfinzi,Tildrakizumab-Asmn,rheumatoid arthritis,hidradenitis suppurativaSun Pharma,Mayo Clinic,Immunology News

This week’s Immunology update highlights regulatory progress, late-stage…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: R1 Therapeutics $77.5 million Series A to treat hyperphosphatemia in CKD dialysis

March 18, 2026clinical trials,chronic kidney disease,nephrology,Regulatory,biopharma,Lucid Diligence Brief,payer access,diligence,venture financing,hyperphosphatemia,dialysisrenal therapeutics

Lucid Diligence Brief: R1 Therapeutics $77.5 million Series A to treat…

by Timos Papagatsias

Obesity Weekly News

Obesity Today—March 17, 2026

March 17, 2026Samsung Bioepis,Eli Lilly And Company,childhood obesity,G2GBIO,semaglutide,BioPharma and Tech News,obesity,Novo Nordisk,Tirzepatide,type 2 diabetes,ASC30,Orforglipron,Obesity News,Ascletis Pharma,icovamenibBiomea Fusion,WHO Foundation

This week’s Obesity update highlights regulatory approvals, emerging generic…

by LucidQuest

Endocrinology

Endocrinology Today—March 17, 2026

March 17, 2026Tegoprubart,Diasens,BioPharma and Tech News,GlucoLive,sotagliflozin,TatvaCare,type 2 diabetes,Dexcom G7,type 1 diabetes,FreeStyle Libre,Endocrinology News,May Health,icovamenib,Anavi System,Biomea Fusion,Polycystic Ovary Syndrome-Related Infertility,Abbott,NewcelX,zydus lifesciences,NCEL-101,Dexcom,Lexicon Pharmaceuticals,InsuletOmnipod 5,Eledon Pharmaceuticals

This week’s Endocrinology update highlights clinical data readouts, device…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide collaboration

March 17, 2026clinical trials,market access,obesity,GLP-1,biopharma,Lucid Diligence Brief,metabolic disease,diligence,Samsung Bioepis,drug deliveryG2GBIO

Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide…

by Timos Papagatsias

Hematology

Hematology Today—March 16, 2026

March 16, 2026ZYNTEGLO,Transfusion-Dependent Beta-Thalassemia,astellas,Mezigdomide,Tecvayli,SLS009,BioPharma and Tech News,Tambiciclib,Johnson & Johnson,XOSPATA,teclistamab,Gilteritinib,Bristol Myers Squibb,NovelMed Therapeutics,Acute Myeloid Leukemia,Ruxoprubart,Paroxysmal Nocturnal Hemoglobinuria,Pierre Fabre Pharmaceuticals,Hematology News,Betibeglogene Autotemcel,SELLAS Life Sciences,Tabelecleucel,Genetix Biotherapeuticsrelapsed refractory multiple myeloma,Lonza

This week’s Hematology update highlights regulatory filings, positive…

by LucidQuest

Onco_background

Oncology Today—March 16, 2026

March 16, 2026Metastatic castration-resistant prostate cancer,Advanced Solid Tumors,Oryzon Genomics,IDEAYA Biosciences,astrazeneca,Aminex Therapeutics,IDE892,BioPharma and Tech News,AMXT 1501,MTAP-Deleted Solid Tumors,ENHERTU,Diffuse Intrinsic Pontine Glioma,Small Cell Lung Cancer,HLX43,Daiichi Sankyo,Squamous Non-Small Cell Lung Cancer,Oncology News,VALANX Biotech,Henlius,VLX-ADC-001,Triple-negative breast cancer,Metastatic Triple-Negative Breast Cancer,Non-muscle invasive bladder cancer,Intensity Therapeutics,Malignant glioma,INT230-6,ImmunityBio,Telix Pharmaceuticals,ANKTIVA,TLX591-Tx,HER2-Positive Early Breast Cancer,Kainova Therapeuticsiadademstat,DT-9081

This week’s Oncology update highlights regulatory progress, pivotal-intent…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 16, 2026

March 16, 2026Veterans Health Administration,PDE5 Inhibitors,BioPharma and Tech News,SynthCity,Retinal Disease,Synthetic Healthcare Data,Microsoft,AI in Healthcare and Digital Health,amyotrophic lateral sclerosis,Metabolic syndrome,Statins,CiteAudit,Copilot Health,RETFound Plus,SynthCraft,AmazonHealth AI,Lawrence Livermore National Laboratory

 This week’s AI in Healthcare and Digital Health update highlights…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.